Edition:
United States

Thermo Fisher Scientific Inc (TMO)

TMO on New York Consolidated

182.16USD
24 Jul 2017
Change (% chg)

-- (--)
Prev Close
$182.16
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,467,122
52-wk High
$182.87
52-wk Low
$139.07

TMO

Chart for TMO

About

Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical... (more)

Overall

Beta: 1.07
Market Cap(Mil.): $71,264.62
Shares Outstanding(Mil.): 391.22
Dividend: 0.15
Yield (%): 0.33

Financials

  TMO Industry Sector
P/E (TTM): 33.19 37.81 15.73
EPS (TTM): 5.49 -- --
ROI: 5.61 8.55 -8.37
ROE: 10.18 13.28 -7.93

BRIEF-Thermo Fisher prices offering of euro-denominated senior notes

* Thermo Fisher Scientific prices offering of euro-denominated senior notes

Jul 18 2017

Fitch Rates Thermo Fisher's EUR2.6B Senior Notes 'BBB'; Outlook Stable

(The following statement was released by the rating agency) NEW YORK, July 18 (Fitch) Fitch Ratings has assigned a 'BBB' rating to Thermo Fisher Scientific Inc.'s (Thermo Fisher) EUR2.6 billion senior notes offering. The proceeds will be used to partly finance the USD7.2 billion acquisition of Patheon N.V. The Rating Outlook is Stable. Thermo Fisher plans to finance the acquisition with $2 billion of equity and approximately $5.2 billion of unsecured notes and short-term debt. Free cash flow gen

Jul 18 2017

BRIEF-Thermo fisher Scientific sets quarterly cash dividend of $0.15 per share

* Sets quarterly cash dividend of $0.15 per share Source text for Eikon: Further company coverage:

Jul 12 2017

BRIEF-Cellink signs distribution agreement with Thermo Fisher Scientific

* CELLINK SIGNS DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC ANZ

Jul 10 2017

BRIEF-Thermo Fisher Scientific announces availability of two new immunoassays

* Thermo fisher scientific announces availability of two new immunoassays designed to maximize detection of synthetic cannabinoids

Jun 28 2017

BRIEF-FDA approves Thermo fisher Scientific's companion diagnostic test to screen multiple non-small cell lung cancer therapies

* FDA approves first companion diagnostic test to simultaneously screen for multiple non-small cell lung cancer therapies

Jun 22 2017

BRIEF-OpGen signs supply agreement to use Thermo Fisher Scientific’S technology

* Opgen signs supply agreement to use thermo fisher scientific’s technology to advance acuitas® rapid test

Jun 19 2017

BRIEF-Thermo Fisher expands access to genome editing with workshop

* Thermo fisher scientific expands access to genome editing with hands-on workshop Source text for Eikon: Further company coverage:

Jun 15 2017

BRIEF-Thermo Fisher Scientific, Biognosys announce co-marketing agreement

* Thermo Fisher Scientific and Biognosys announce co-marketing agreement to create industry-leading data-independent acquisition workflows

Jun 05 2017

BRIEF-Patheon says to be obligated to pay Thermo Fisher termination compensation of $203 million in cash

* Patheon NV - under termination of deal in certain circumstances, co to be obligated to pay thermo fisher termination compensation of $203 million in cash Source text for Eikon: (http://bit.ly/2qGr8XK) Further company coverage:

May 19 2017

Earnings vs. Estimates